MyoKardia Inc fka MYOK

[Bernstein]

$1.2 BILLION for a one trick pony junk which still has to conduct a large phase 3 trial which will take years to finish is for me definitely brutally overpriced . And a 10 patients trial is a big joke almost every Drug works in such small numbers of patients its even worthless to talk about these results . Oh and look at the dumping by Insiders and Institutions in last days , FMR as an example dumped 1.6 million shares yesterday they know this heavily pumped trash has an astronomical valuation .